Revised SPC: Norditropin (somatropin) products

SPC now highlights that although rare, pancreatitis should be considered in somatropin-treated patients who develop abdominal pain, especially in children. It also now includes gynecomastia in adults and children as an uncommon adverse effect

Source:

electronic Medicines compendium